前大隐静脉第4部分:治疗中的临床与技术考量——美国静脉与淋巴学会、美国静脉论坛及国际静脉学联盟共同认可
本文由专家组讨论前大隐静脉(ASV)反流的治疗决策,识别解剖、临床与技术考量,包括是否同期处理大隐静脉(GSV)与ASV、GSV反流时正常ASV是否处理及属支静脉曲张的处理时机与方式,强调以患者为中心制定个体化治疗计划以优化长期结局。
要点
- 治疗反流ASV的决策应基于ASV对患者体征和症状的贡献。
- 需考虑是否同期处理GSV与ASV,以及GSV反流时正常ASV是否处理。
- 需考量相关属支静脉曲张的处理时机与方式。
核心结论
- 最终治疗计划应针对这些变量进行个体化,并以患者为中心的讨论制定。
研究设计与样本
- 专家组讨论临床场景,识别常见的解剖、临床与技术考量。
主要发现
- 存在独特的临床考量,如是否同期处理GSV与ASV、GSV反流时正常ASV是否处理及相关属支静脉曲张的处理时机与方式。
- 了解解剖、临床与技术考量有助于制定优化ASV反流患者长期结局的治疗计划。
临床怎么用
- 治疗反流ASV的决策应基于对ASV在患者体征和症状中贡献的评估,一旦决定治疗,需在治疗计划中考虑解剖、临床与技术因素。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The decision to treat a refluxing anterior saphenous vein (ASV) should be a clinical decision based on the assessment on the ASV's contribution to patient's signs and symptoms. Once the decision to treat has been made, there are anatomic, clinical, and technical considerations in treatment planning. METHODS: Clinical scenarios were discussed by a panel of experts and common anatomic, clinical, and technical considerations were identified. RESULTS: There are unique clinical considerations such as whether both the great saphenous vein (GSV) and ASV should be concomitantly treated, if a normal ASV should be treated when treating a refluxing GSV and when and how to treat the associated tributary varicose tributaries. Being aware of the anatomic, clinical, and technical considerations allows development of a treatment plan that optimizes long-term outcomes in patients with ASV reflux. CONCLUSIONS: Ultimately the treatment plan should be tailored to address these types of variables in a patient-centered discussion.
引用
- Boyle EM, Drgastin R, Labropoulos N, et al. The anterior saphenous vein. Part 4. Clinical and technical considerations in treatment. Endorsed by the American Vein and Lymphatic Society, the American Venous Forum, and the International Union of Phlebology. J Vasc Surg Venous Lymphat Disord. 2024. PMID: 38551526. doi:10.1016/j.jvsv.2024.101857
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。